Categories
Change Password!
Reset Password!
Sublingual immunotherapy displays noteworthy effic...
Abrocitinib 100mg predicts week 12 success in atop...
Research in 'Dermatology and Therapy' aimed to predict the early efficacy of Abrocitinib in atopic dermatitis, suggesting potential for e...
Remineralizing roots: A study on toothpastes for a...
Innovative toothpastes with biomimetic and re-mineralising properties have been shown to have great potential against enamel demineralisation as...
Omalizumab proves to be effective in treating food...
Food allergies, a growing concern with significant health impacts, currently have limited treatment options. A recent study in ‘The New Eng...
Variations in chronic inducible urticaria: subtype...
CInducibleU is a kind of chronic urticaria (hives) triggered by specific factors. It can occur alone or alongside chronic spontaneous urticaria (...
Rapidly improved patient-reported outcomes with th...
The integrated data from the two clinical trials suggested that Upadacitinib monotherapy rapidly and effectively improved patient-reported outcom...
Chronic spontaneous urticaria revealed: Non-skin s...
The Journal of Allergy and Clinical Immunology's recent article investigated the prevalence of fever, joint pain, and malaise among chronic s...
Annual Allergen of the Year Award
To highlight allergens with significant clinical impact, bring awareness to under-recognized agents, and acknowledge those that have become outda...
20-year trajectory of risk and progression of poll...
Allergic rhinitis (AR) is a widespread chronic condition, but long-term data on its persistence and remission are scarce. This study explored the...
One-of-a-kind non-injection nasal spray is now FDA...
The FDA-approved Epinephrine nasal spray for type I allergic reactions, including potentially fatal anaphylaxis in emergencies, was mentioned in...
